摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (E)-3-(4-amino-3-hydroxyphenyl)-2-methylprop-2-enoate;hydrochloride

中文名称
——
中文别名
——
英文名称
ethyl (E)-3-(4-amino-3-hydroxyphenyl)-2-methylprop-2-enoate;hydrochloride
英文别名
——
ethyl (E)-3-(4-amino-3-hydroxyphenyl)-2-methylprop-2-enoate;hydrochloride化学式
CAS
——
化学式
C12H16ClNO3
mdl
——
分子量
257.71
InChiKey
VWQBGEIFSOLNIO-WVLIHFOGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.36
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    72.6
  • 氢给体数:
    3
  • 氢受体数:
    4

文献信息

  • [EN] THROMBOPOIETIN MIMETICS<br/>[FR] MIMETIQUES DE LA THROMBOPOIETINE
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2003103686A1
    公开(公告)日:2003-12-18
    Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy­1-azobenzene derivative.
    发明了非肽类TPO拟物。还发明了用于制备目前发明的化合物的新工艺和中间体。还发明了一种治疗血小板减少症的方法,包括给予需要的哺乳动物,包括人类,有效量的选定羟基-1-偶氮苯衍生物。
  • Novel compounds and a novel process for their preparation
    申请人:Fagnou Keith
    公开号:US20050014721A1
    公开(公告)日:2005-01-20
    The present invention is directed to a procedure for making an enantiomerically enriched compound containing a hydronaphthalene ring structure. The process involves reacting oxabenzonorbornadienes with nucleophiles using rhodium as a catalyst and in the presence of a phosphine ligand. The compounds synthesized may be used in pharmaceutical preparations for the treatment of a variety of diseases and conditions.
    本发明涉及一种制备含有氢化萘环结构的对映体富集化合物的方法。该过程涉及使用铑作为催化剂,并在膦配体的存在下,将氧化苯并[2,3-c]环辛二烯与亲核试剂反应。合成的化合物可用于制备治疗各种疾病和病况的药物制剂。
  • Thrombopoietin mimetics
    申请人:Heerding A. Dirk
    公开号:US20050234020A1
    公开(公告)日:2005-10-20
    Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    本文介绍了一种非肽类TPO类似物的发明。还发明了用于制备该类化合物的新型工艺和中间体。同时,发明了一种治疗血小板减少症的方法,该方法包括向需要治疗的哺乳动物(包括人类)中注入所选的羟基-1-偶氮苯衍生物的有效剂量。
  • THROMBOPOIETIN MIMETICS
    申请人:Smithkline Beecham
    公开号:EP1556059A1
    公开(公告)日:2005-07-27
  • US6525068B1
    申请人:——
    公开号:US6525068B1
    公开(公告)日:2003-02-25
查看更多